Alvotech (ALVO) FCF Margin (2022 - 2026)
Alvotech's (ALVO) quarterly FCF Margin came in at 35.37% in Q1 2026, down 7229.0% YoY from 0.5% in Q1 2025, and down 150.49% on a QoQ basis from 70.05% in Q4 2025.
Alvotech (ALVO) FCF Margin (2022 - 2026) Analysis & Trends
Alvotech (ALVO) has 5 years of FCF Margin data on file, last reported at 35.37% in Q1 2026.
- Quarterly FCF Margin fell 7229.0% year-over-year to 35.37% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 79.68% (down 8170.0% YoY) and the FY2025 annual result came in at 41.51%, up 6472.0% from the prior year.
- FCF Margin slipped to 35.37% in Q1 2026, from 70.05% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 70.05% in Q4 2025 to a low of 8314.6% in Q1 2022.
- A 5-year average of 1049.86% and a median of 35.37% in 2026 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin jumped 831413 bps — and 2025, when it tumbled 66345 bps.
- Tracing ALVO's FCF Margin over 5 years: stood at 1992.66% in 2022, then climbed by 26 bps to 1476.01% in 2023, then surged by 81 bps to 277.92% in 2024, then surged by 125 bps to 70.05% in 2025, then plunged by 150 bps to 35.37% in 2026.
- The last three FCF Margin figures came in at 35.37% (Q1 2026), 70.05% (Q4 2025), and 756.55% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alvotech | 1.22 Bn | 1.22 Bn | 5.09 Mn | -104.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.37% |
| Dec 31, 2025 | 70.05% |
| Sep 30, 2025 | -756.55% |
| Jun 30, 2025 | 68.04% |
| Mar 31, 2025 | 36.91% |
| Dec 31, 2024 | -277.92% |
| Sep 30, 2024 | -93.10% |
| Jun 30, 2024 | 0.36% |
| Mar 31, 2024 | -0.57% |
| Dec 31, 2023 | -1,476.01% |
| Jun 30, 2023 | 0.19% |
| Mar 31, 2023 | -0.47% |
| Dec 31, 2022 | -1,992.66% |
| Jun 30, 2022 | -2,976.26% |
| Mar 31, 2022 | -8,314.60% |